DnB Asset Management’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $8.96M | Buy |
27,463
+166
| +0.6% | +$54.1K | 0.04% | 282 |
|
|
2025
Q1 | $7.37M | Buy |
27,297
+564
| +2% | +$152K | 0.03% | 307 |
|
|
2024
Q4 | $6.29M | Buy |
26,733
+1,335
| +5% | +$314K | 0.03% | 344 |
|
|
2024
Q3 | $6.99M | Sell |
25,398
-617
| -2% | -$170K | 0.03% | 327 |
|
|
2024
Q2 | $6.32M | Buy |
26,015
+1,022
| +4% | +$248K | 0.03% | 308 |
|
|
2024
Q1 | $3.74M | Sell |
24,993
-21,231
| -46% | -$3.17M | 0.02% | 402 |
|
|
2023
Q4 | $8.85M | Sell |
46,224
-4,988
| -10% | -$955K | 0.05% | 261 |
|
|
2023
Q3 | $9.07M | Buy |
51,212
+25,898
| +102% | +$4.59M | 0.05% | 243 |
|
|
2023
Q2 | $4.81M | Buy |
25,314
+1,996
| +9% | +$379K | 0.03% | 362 |
|
|
2023
Q1 | $4.67M | Buy |
23,318
+1,121
| +5% | +$225K | 0.03% | 381 |
|
|
2022
Q4 | $5.28M | Buy |
22,197
+1,214
| +6% | +$289K | 0.04% | 340 |
|
|
2022
Q3 | $4.2M | Sell |
20,983
-244
| -1% | -$48.8K | 0.03% | 360 |
|
|
2022
Q2 | $3.1M | Sell |
21,227
-128
| -0.6% | -$18.7K | 0.02% | 436 |
|
|
2022
Q1 | $3.49M | Buy |
21,355
+1,868
| +10% | +$305K | 0.02% | 449 |
|
|
2021
Q4 | $3.3M | Buy |
19,487
+1,670
| +9% | +$283K | 0.02% | 461 |
|
|
2021
Q3 | $3.36M | Sell |
17,817
-108
| -0.6% | -$20.4K | 0.02% | 427 |
|
|
2021
Q2 | $3.04M | Sell |
17,925
-5,461
| -23% | -$926K | 0.02% | 463 |
|
|
2021
Q1 | $3.3M | Buy |
23,386
+7,629
| +48% | +$1.08M | 0.02% | 425 |
|
|
2020
Q4 | $2.05M | Buy |
15,757
+2,322
| +17% | +$302K | 0.02% | 459 |
|
|
2020
Q3 | $1.96M | Sell |
13,435
-78
| -0.6% | -$11.4K | 0.02% | 405 |
|
|
2020
Q2 | $2M | Buy |
13,513
+2,938
| +28% | +$435K | 0.02% | 386 |
|
|
2020
Q1 | $1.15M | Sell |
10,575
-1,889
| -15% | -$206K | 0.02% | 459 |
|
|
2019
Q4 | $1.44M | Buy |
12,464
+1,109
| +10% | +$128K | 0.01% | 520 |
|
|
2019
Q3 | $913K | Buy |
+11,355
| New | +$913K | 0.01% | 559 |
|
|
2019
Q1 | – | Sell |
-10,261
| Closed | -$748K | – | 626 |
|
|
2018
Q4 | $748K | Buy |
10,261
+48
| +0.5% | +$3.5K | 0.01% | 556 |
|
|
2018
Q3 | $894K | Buy |
+10,213
| New | +$894K | 0.01% | 549 |
|